Railway Pension Investments LTD Neurocrine Biosciences Inc Transaction History

Railway Pension Investments LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$86.91 - $108.33 $1.9 Million - $2.37 Million	-21,900 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$96.16 - $135.15 $19,232 - $27,030	200 Added 0.92%	21,900 $2.11 Million
Q2 2020 Jul 22, 2020	BUY	$85.09 - $130.36 $42,545 - $65,180	500 Added 2.36%	21,700 $2.65 Million
Q1 2020 Apr 22, 2020	BUY	$75.11 - $113.76 $150,220 - $227,520	2,000 Added 10.42%	21,200 $1.83 Million
Q4 2019 Feb 03, 2020	BUY	$86.8 - $118.57 $1.67 Million - $2.28 Million	19,200 New	19,200 $2.06 Million

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Railway Pension Investments LTD with notifications on news.